Transcriptome profiles associated to VHSV infection or DNA vaccination in turbot (Scophthalmus maximus)

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Pereiro, Patricia ^a   Dios, Sonia ^a   Boltaña, Sebastián ^b,e   Coll, Julio ^c   Estepa, Amparo ^d   Mackenzie, Simon ^b,e   Novoa, Beatriz ^a   Figueras, Antonio ^a  

^a INSTITUTO DE INVESTIGACIONES MARINAS   (Spain)

^b UNIVERSITY OF STIRLING   (United Kingdom)

^c INIA   (Spain)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CASPASE 10; CASPASE 6; CASPASE 7; CASPASE 8; COMPLEMENT; DNA VACCINE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; I KAPPA B KINASE; I KAPPA B KINASE BETA; I KAPPA B KINASE ZETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON INDUCIBLE REGULATOR PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1BETA CONVERTING ENZYME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BAX; REGULATOR PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 13; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 8; TRANSCRIPTOME; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE ASSOCIATION; DNA IMMUNIZATION; GENE EXPRESSION PROFILING; HEAD KIDNEY; INNATE IMMUNITY; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; SCOPHTHALMUS MAXIMUS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; TREATMENT OUTCOME; TURBOT; VIRAL HEMORRHAGIC SEPTICEMIA; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS; ANIMAL; DRUG EFFECTS; FISH DISEASES; FLATFISH; METABOLISM; NOVIRHABDOVIRUS; RHABDOVIRIDAE INFECTIONS; VETERINARY;

ANIMALS; FISH DISEASES; FLATFISHES; NOVIRHABDOVIRUS; RHABDOVIRIDAE INFECTIONS; TRANSCRIPTOME; VACCINES, DNA; VIRAL VACCINES;

EID: 84905493180     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104509     Document Type: Article

References (72)

1. Wolf K (1988) Viral hemorrhagic septicemia. In: Fish Viruses and Fish Viral Diseases, Ithaca, New York: Cornell University Press. pp. 217-249.
2. Castric J, de Kinkelin P (1980) Occurrence of viral haemorrhagic septicaemia in rainbow trout Salmo gairdneri Richardson reared in sea water. J Fish Dis 3: 21-27.
3. Hørlyck V, Mellergård S, Dalsgaard I, Jørgensen PEV (1984) Occurrence of VHSV in Danish maricultured rainbowtrout. Bull Eur Fish Pathol 4: 11-13.
4. Schlotfeldt HJ, Ahne W, Vestergård-Jørgensen PE, Glende W (1991) Occurrence of viral haemorrhagic septicaemia virus in turbot (Scophthalmus maximus) - a natural outbreak. Bull Eur Assoc Fish Pathol 11: 105-107.
5. Ross K, McCarthy U, Huntly PJ, Wood BP, Stuart D, et al. (1994) An outbreak of viral haemorrhagic septicemia (VHS) in turbot (Scophthalmus maximus) in Scotland. Bull Eur Assoc Fish Pathol 14: 213-214.
6. de Kinkelin, P., Bearzotti-Le Berre, M Bernard, J. (1980) Viral hemorrhagic septicemia of rainbow trout: selection of a thermoresistant virus variant and comparison of polypeptide synthesis with the wild-type virus strain. J Virol 36: 652-658. (Pubitemid 11194304)
7. Bernard J, de Kinkelin P, Bearzotti-Le Berre M (1983) Viral hemorrhagic septicemia of rainbow trout: relation between the G polypeptide and antibody production in protection of the fish after infection with the F25 attenuated variant. Infect Immun 39: 7-14. (Pubitemid 13212490)
8. Leong JC, Fryer JL (1993) Viral vaccines for aquaculture. Annu Rev Fish Dis 3: 225-240.
9. Lecocq-Xhonneux F, Thiry M, Dheur I, Rossius M, Vanderheijden N, et al. (1994) A recombinant viral haemorrhagic septicaemia virus glycoprotein expressed in insect cells induces protective immunity in rainbow trout. J Gen Virol 75: 1579-1587. (Pubitemid 24211243)
10. de Kinkelin P, Béarzotti M, Castric J, Nougayrède P, Lecocq-Xhonneux F, et al. (1995) Eighteen years of vaccination against viral haemorrhagic septicaemia in France. Vet Res 26: 379-387.
11. Adelmann M, Köllner BK, Bergmann SM, Fischer U, Lange B, et al. (2008) Development of an oral vaccine for immunisation of rainbow trout (Oncorhynchus mykiss) against viral haemorrhagic septicaemia. Vaccine 26: 837-844.
12. Lorenzen N, Olesen NJ, Jorgensen PEV (1990) Neutralization of Egtved virus pathogenicity to cell cultures and fish by monoclonal antibodies to the viral G protein. J Gen Virol 71: 561-567. (Pubitemid 20111899)
13. Pereiro P, Martinez-Lopez A, Falco A, Dios S, Figueras A, et al. (2012) Protection and antibody response induced by intramuscular DNA vaccine encoding for viral haemorrhagic septicaemia virus (VHSV) G glycoprotein in turbot (Scophthalmus maximus). Fish Shellfish Immunol 32: 1088-1094.
14. Purcell MK, Nichols KM, Winton JR, Kurath G, Thorgaard GH, et al. (2006) Comprehensive gene expression profiling following DNA vaccination of rainbow trout against infectious hematopoietic necrosis virus. Mol Immunol 43: 2089-2106.
15. Byon JY, Ohira T, Hirono I, Aoki T (2005) Use of a cDNA microarray to study immunity against viral hemorrhagic septicemia (VHS) in Japanese flounder (Paralichthys olivaceus) following DNA vaccination. Fish Shellfish Immunol 18: 135-147. (Pubitemid 39308560)
16. Byon JY, Ohira T, Hirono I, Aoki T (2006) Comparative immune responses in Japanese flounder, Paralichthys olivaceus after vaccination with viral hemorrhagic septicemia virus (VHSV) recombinant glycoprotein and DNA vaccine using a microarray analysis. Vaccine 24: 921-930. (Pubitemid 43185308)
17. Yasuike M, Kondo H, Hirono I, Aoki T (2007) Difference in Japanese flounder, Paralichthys olivaceus gene expression profile following hirame rhabdovirus (HIRRV) G and N protein DNA vaccination. Fish Shellfish Immunol 23: 531-541. (Pubitemid 47048733)
18. Yasuike M, Kondo H, Hirono I, Aoki T (2011) Gene expression profile of HIRRV G and N protein gene vaccinated Japanese flounder, Paralichthys olivaceus during HIRRV infection. Comp Immunol Microbiol Infect Dis. 34: 103-110.
19. Pereiro P, Balseiro P, Romero A, Dios S, Forn-Cuni G, et al. (2012) High-throughput sequence analysis of turbot (Scophthalmus maximus) transcriptome using 454-pyrosequencing for the discovery of antiviral immune genes. PLoS ONE 7(5): e35369.
20. Reed LJ, Muench H (1938) Simple method of estimating fifty per cent endpoints. Am J Hyg 27: 493-497.
21. Conesa A, Götz S, García-Gómez JM, Terol J, Talon M, et al. (2005) Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 21: 3674-3676. (Pubitemid 41264107)
22. Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. MIMB 132: 365-386.
23. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
24. Morey JS, Ryan JC, Van Dolah FM (2006) Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online 8: 175-193. (Pubitemid 44942143)
25. Lorenzen N, LaPatra SE (2005) DNA vaccines for aquacultured fish. Rev sci tech Off int Epi 24: 201-213.
26. Krieg AM, Yi AK, Schorr J, Davis HL (1998) The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 6: 23-27. (Pubitemid 28068882)
27. Manders P, Thomas R (2000) Immunology of DNA vaccines: CpG motifs and antigen presentation. Trends Microbiol49: 199-205. (Pubitemid 30353685)
28. Martinez-Alonso S, Martinez-Lopez A, Estepa A, Cuesta A, Tafalla C (2011) The introduction of multi-copy CpG motifs into an antiviral DNA vaccine strongly up-regulated its immunogenicity in fish. Vaccine 29: 1289-1296.
29. Klinman DM, Currie D, Gursel I, Verthelyi D (2004) Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199: 201-216. (Pubitemid 38736773)
30. Ritter GMG, Muñoz JE, Marques AF, Nosanchuck JD, Taborda CP, et al. (2012) Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis. PLoS Negl Trop Dis 6: e1519.
31. Ha SJ, Jeon BY, Kim SC, Kim DJ, Song MK, et al. (2003) Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Ther 10: 1592-1599.
32. Jørgensen JB, Johansen LH, Steiro K, Johansen A (2003) CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.).J Virol 77: 11471-11479. (Pubitemid 37271645)
33. Kim CH, Johnson MC, Drennan JD, Simon BE, Thomann E, et al. (2000) DNA vaccines encoding viral glycoproteins induce nonspecific immunity and Mx protein synthesis in fish. J Virol 74: 7048-7054. (Pubitemid 30470688)
34. LaPatra SE, Corbeil S, Jones GR, Shewmaker WD, Lorenzen N, et al. (2001) Protection of rainbow trout against infectious hematopoietic necrosis virus four days after specific or semi-specific DNA vaccination. Vaccine 19: 4011-4019. (Pubitemid 32566326)
35. Sommerset I, Lorenzen E, Lorenzen N, Bleie H, Nerland AH (2003) A DNA vaccine directed against a rainbow trout rhabdovirus induces early protection against a nodavirus challenge in turbot. Vaccine 21: 4661-4667. (Pubitemid 37329860)
36. Lorenzen E, Lorenzen N, Einer-Jensen K, Brudeseth B, Evensen O (2005) Time course study of in situ expression of antigens following DNA-vaccination against VHS in rainbow trout (Oncorhynchus mykiss Walbaum) fry. Fish Shellfish Immunol 19: 27-41. (Pubitemid 40252997)
37. Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22: 240-273.
38. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
39. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
40. Uematsu S, Akira S (2007) Toll-like receptors and type I interferons. J Biol Chem 282: 15319-15323.
41. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644-658. (Pubitemid 44298214)
42. Xagorari A, Chlichlia K (2008) Toll-like receptors and viruses: induction of innate antiviral immune responses. Open Microbiol J 2: 49-59.
43. Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A (2000) The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J 19: 3325-3336. (Pubitemid 30428210)
44. Hidmark A, von Saint Paul A, Dalpke AH (2012) Cutting edge: TLR13 is a receptor for bacterial RNA. J Immunol 189: 2717-2721.
45. Shi Z, Cai Z, Sanchez A, Zhang T, Wen S, et al. (2011) A novel Toll-like receptor that recognizes vesicular stomatitis virus. J Biol Chem 286: 4517-4524.
46. Goodbourn S, Didcock L, Randall RE (2000) Interferons: cell signaling, immune modulation, antiviral responses and virus countermeasures. J Gen Virol 81: 2341-2364.
47. Zou J, Secombes CJ (2011) Teleost fish interferons and their role in immunity. Dev Comp Immunol 35: 1376-1387.
48. Pereiro P, Costa MM, Díaz-Rosales P, Dios S, Figueras A, et al. (2014) The first characterization of two type I interferons in turbot (Scophthalmus maximus) reveals their differential role, expression pattern and gene induction. Dev Comp Immunol 45: 233-244.
49. Fensterl V, Sen GC (2011) The ISG56/IFIT1 gene family. J Interferon Cytokine Res 31: 71-78.
50. Barber GN (2001) Host defense, viruses and apoptosis. Cell Death Differ 8: 113-126.
51. Trapani JA, Smyth MJ (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2: 735-747. (Pubitemid 37328714)
52. Røder G, Geironson L, Bressendorff I, Paulsson K (2008) Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex. J Virol 82: 8246-8252.
53. Brode S, Macary PA (2004) Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology 112: 345-351. (Pubitemid 38859511)
54. Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17: 1807-1819. (Pubitemid 44036165)
55. Hewitt EW (2003) The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110: 163-169.
56. Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, et al. (2010) Molecular intercommunication between the complement and coagulation system. J Immunol 185: 5628-36.
57. Levi M, Keller TT, van Gorp E, ten Cate H (2003) Infection and inflammation and the coagulation system. Cardiovasc Res 60: 26-39. (Pubitemid 38373473)
58. Esmon CT (2003) Inflammation and thrombosis. J Thromb Haemost 1: 1343-1348.
59. Glaros T, Larsen M, Li L (2009) Macrophages and fibroblast during inflammation, tissue damage and organ injury. Front Biosci 14: 3988-3993.
60. Carroll MC (2004) The complement system in regulation of adaptive immunity. Nat Immunol 5: 981-986.
61. Luo RF. Zhao S, Tibshirani R, Myklebust JH, Sanyal M, et al. (2010) CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Hum Pathol 41: 271-280.
62. Chang LL, Cheng PN, Chen JS, Young KC (2007) CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection. Antiviral Res 75: 43-51.
63. Stein M, Keshav S, Harris N, Gordon S (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292.
64. Harris N, Super M, Rits M, Chang G, Ezekowitz RA (1992) Characterization of the murine macrophage mannose receptor: demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription. Blood 80: 2363-2373.
65. Zhou LJ, Tedder TF (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93: 2588-2592.
66. Iking-Konert C, Wagner C, Denefleh B, Hug F, Schneider M, et al. (2002) Up-regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease. Clin Exp Immunol 130: 501-508. (Pubitemid 35418335)
67. Tafalla C, Figueras A, Novoa B (1998) In vitro interaction of viral haemorrhagic septicaemia virus and leukocytes from trout (Oncorhynchus mykiss) and turbot (Scophthalmus maximus). Vet Immunol Immunopathol 62: 359-366. (Pubitemid 28270895)
68. Morahan PS, Connor JR, Leary KR (1985) Viruses and the versatile macrophage. Br Med Bull 41: 15-21. (Pubitemid 15165170)
69. Wu L, Morahan PS, Leary K (1990) Mechanisms of intrinsic macrophage-virus interactions in vitro. Microbiol Pathol 9: 293-301.
70. Dakhama A, Kaan PM, Hegele RG (1998) Permissiveness of guinea pig alveolar macrophage subpopulations to acute respiratory syncytial virus infection in vitro. Chest 114: 1681-1608.
71. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H (2001) Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 12: 53-72. (Pubitemid 32294587)
72. Boraschi D, Dinarello CA (2006) IL-18 in autoimmunity: review. Eur Cytokine Netw 17: 224-252.